Single Cell RNA Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511246122

Publication Date:

November 21, 2024

Pages:

105

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Single-cell RNA sequencing (scRNA-seq) is a genomic technology that allows researchers to study gene expression at the level of individual cells. It involves isolating and sequencing the RNA from individual cells, providing a snapshot of the genes being actively transcribed in each cell. This technique has revolutionized the field of transcriptomics by enabling researchers to examine cellular heterogeneity and discover rare cell populations.
The global market for Single Cell RNA Sequencing was estimated to be worth US$ 1800 million in 2023 and is forecast to a readjusted size of US$ 7402.9 million by 2030 with a CAGR of 21.3% during the forecast period 2024-2030
North American market for Single Cell RNA Sequencing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Single Cell RNA Sequencing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Single Cell RNA Sequencing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Single Cell RNA Sequencing include PerkinElmer, Illumina, Dolomite Bio, TAKARA BIO, Thermo Fisher, Roche, Oxford Nanopore Technologies, Qiagen and LC Sciences, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Single Cell RNA Sequencing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Single Cell RNA Sequencing by region & country, by Type, and by Application.
The Single Cell RNA Sequencing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single Cell RNA Sequencing.
Market Segmentation
By Company
PerkinElmer
Illumina
Dolomite Bio
TAKARA BIO
Thermo Fisher
Roche
Oxford Nanopore Technologies
Qiagen
LC Sciences
Pacific Biosciences
Segment by Type:
Non-Coding RNA Sequencing
Direct RNA Sequencing
Segment by Application
Research Institutions
Bioscience Companies
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Single Cell RNA Sequencing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Single Cell RNA Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Single Cell RNA Sequencing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Single Cell RNA Sequencing Product Introduction
1.2 Global Single Cell RNA Sequencing Market Size Forecast
1.3 Single Cell RNA Sequencing Market Trends & Drivers
1.3.1 Single Cell RNA Sequencing Industry Trends
1.3.2 Single Cell RNA Sequencing Market Drivers & Opportunity
1.3.3 Single Cell RNA Sequencing Market Challenges
1.3.4 Single Cell RNA Sequencing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Single Cell RNA Sequencing Players Revenue Ranking (2023)
2.2 Global Single Cell RNA Sequencing Revenue by Company (2019-2024)
2.3 Key Companies Single Cell RNA Sequencing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Single Cell RNA Sequencing Product Offered
2.5 Key Companies Time to Begin Mass Production of Single Cell RNA Sequencing
2.6 Single Cell RNA Sequencing Market Competitive Analysis
2.6.1 Single Cell RNA Sequencing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Single Cell RNA Sequencing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Cell RNA Sequencing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Non-Coding RNA Sequencing
3.1.2 Direct RNA Sequencing
3.2 Global Single Cell RNA Sequencing Sales Value by Type
3.2.1 Global Single Cell RNA Sequencing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Single Cell RNA Sequencing Sales Value, by Type (2019-2030)
3.2.3 Global Single Cell RNA Sequencing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Research Institutions
4.1.2 Bioscience Companies
4.1.3 Others
4.2 Global Single Cell RNA Sequencing Sales Value by Application
4.2.1 Global Single Cell RNA Sequencing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Single Cell RNA Sequencing Sales Value, by Application (2019-2030)
4.2.3 Global Single Cell RNA Sequencing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Single Cell RNA Sequencing Sales Value by Region
5.1.1 Global Single Cell RNA Sequencing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Single Cell RNA Sequencing Sales Value by Region (2019-2024)
5.1.3 Global Single Cell RNA Sequencing Sales Value by Region (2025-2030)
5.1.4 Global Single Cell RNA Sequencing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Single Cell RNA Sequencing Sales Value, 2019-2030
5.2.2 North America Single Cell RNA Sequencing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Single Cell RNA Sequencing Sales Value, 2019-2030
5.3.2 Europe Single Cell RNA Sequencing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Single Cell RNA Sequencing Sales Value, 2019-2030
5.4.2 Asia Pacific Single Cell RNA Sequencing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Single Cell RNA Sequencing Sales Value, 2019-2030
5.5.2 South America Single Cell RNA Sequencing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Single Cell RNA Sequencing Sales Value, 2019-2030
5.6.2 Middle East & Africa Single Cell RNA Sequencing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Single Cell RNA Sequencing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Single Cell RNA Sequencing Sales Value
6.3 United States
6.3.1 United States Single Cell RNA Sequencing Sales Value, 2019-2030
6.3.2 United States Single Cell RNA Sequencing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Single Cell RNA Sequencing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Single Cell RNA Sequencing Sales Value, 2019-2030
6.4.2 Europe Single Cell RNA Sequencing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Single Cell RNA Sequencing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Single Cell RNA Sequencing Sales Value, 2019-2030
6.5.2 China Single Cell RNA Sequencing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Single Cell RNA Sequencing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Single Cell RNA Sequencing Sales Value, 2019-2030
6.6.2 Japan Single Cell RNA Sequencing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Single Cell RNA Sequencing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Single Cell RNA Sequencing Sales Value, 2019-2030
6.7.2 South Korea Single Cell RNA Sequencing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Single Cell RNA Sequencing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Single Cell RNA Sequencing Sales Value, 2019-2030
6.8.2 Southeast Asia Single Cell RNA Sequencing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Single Cell RNA Sequencing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Single Cell RNA Sequencing Sales Value, 2019-2030
6.9.2 India Single Cell RNA Sequencing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Single Cell RNA Sequencing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 PerkinElmer
7.1.1 PerkinElmer Profile
7.1.2 PerkinElmer Main Business
7.1.3 PerkinElmer Single Cell RNA Sequencing Products, Services and Solutions
7.1.4 PerkinElmer Single Cell RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.1.5 PerkinElmer Recent Developments
7.2 Illumina
7.2.1 Illumina Profile
7.2.2 Illumina Main Business
7.2.3 Illumina Single Cell RNA Sequencing Products, Services and Solutions
7.2.4 Illumina Single Cell RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.2.5 Illumina Recent Developments
7.3 Dolomite Bio
7.3.1 Dolomite Bio Profile
7.3.2 Dolomite Bio Main Business
7.3.3 Dolomite Bio Single Cell RNA Sequencing Products, Services and Solutions
7.3.4 Dolomite Bio Single Cell RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.3.5 TAKARA BIO Recent Developments
7.4 TAKARA BIO
7.4.1 TAKARA BIO Profile
7.4.2 TAKARA BIO Main Business
7.4.3 TAKARA BIO Single Cell RNA Sequencing Products, Services and Solutions
7.4.4 TAKARA BIO Single Cell RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.4.5 TAKARA BIO Recent Developments
7.5 Thermo Fisher
7.5.1 Thermo Fisher Profile
7.5.2 Thermo Fisher Main Business
7.5.3 Thermo Fisher Single Cell RNA Sequencing Products, Services and Solutions
7.5.4 Thermo Fisher Single Cell RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.5.5 Thermo Fisher Recent Developments
7.6 Roche
7.6.1 Roche Profile
7.6.2 Roche Main Business
7.6.3 Roche Single Cell RNA Sequencing Products, Services and Solutions
7.6.4 Roche Single Cell RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.6.5 Roche Recent Developments
7.7 Oxford Nanopore Technologies
7.7.1 Oxford Nanopore Technologies Profile
7.7.2 Oxford Nanopore Technologies Main Business
7.7.3 Oxford Nanopore Technologies Single Cell RNA Sequencing Products, Services and Solutions
7.7.4 Oxford Nanopore Technologies Single Cell RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.7.5 Oxford Nanopore Technologies Recent Developments
7.8 Qiagen
7.8.1 Qiagen Profile
7.8.2 Qiagen Main Business
7.8.3 Qiagen Single Cell RNA Sequencing Products, Services and Solutions
7.8.4 Qiagen Single Cell RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.8.5 Qiagen Recent Developments
7.9 LC Sciences
7.9.1 LC Sciences Profile
7.9.2 LC Sciences Main Business
7.9.3 LC Sciences Single Cell RNA Sequencing Products, Services and Solutions
7.9.4 LC Sciences Single Cell RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.9.5 LC Sciences Recent Developments
7.10 Pacific Biosciences
7.10.1 Pacific Biosciences Profile
7.10.2 Pacific Biosciences Main Business
7.10.3 Pacific Biosciences Single Cell RNA Sequencing Products, Services and Solutions
7.10.4 Pacific Biosciences Single Cell RNA Sequencing Revenue (US$ Million) & (2019-2024)
7.10.5 Pacific Biosciences Recent Developments
8 Industry Chain Analysis
8.1 Single Cell RNA Sequencing Industrial Chain
8.2 Single Cell RNA Sequencing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Single Cell RNA Sequencing Sales Model
8.5.2 Sales Channel
8.5.3 Single Cell RNA Sequencing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

PerkinElmer
Illumina
Dolomite Bio
TAKARA BIO
Thermo Fisher
Roche
Oxford Nanopore Technologies
Qiagen
LC Sciences
Pacific Biosciences

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂